Maine

Overview

Maine was an early medical-cannabis state, legalizing the medical use of cannabis via Question 2 of November 2, 1999. Adult-use cannabis was legalized via Question 1 of November 8, 2016 (the Marijuana Legalization Act, 50.3% approval) codified at Maine Revised Statutes Title 28-B. Licensed adult-use retail sales began October 9, 2020.

The Maine Office of Cannabis Policy (OCP), within the Department of Administrative and Financial Services, regulates both the adult-use and medical programs.

Adult-use (Title 28-B, 2016)

• Public possession: 2.5 ounces of cannabis flower or 5 grams of concentrate.
• Home cultivation: up to 3 mature plants, 12 immature plants, and an unlimited number of seedlings per adult.
• Tax: 10% retail sales tax plus excise tax paid by the cultivator.

Medical program (Title 22 Chapter 558-C, 1999)

Qualifying conditions

The Maine medical program lists a broad enumerated set of qualifying conditions plus practitioner discretion:

• Cancer, glaucoma, HIV/AIDS, ALS
• Crohn's disease, inflammatory bowel disease
• Multiple sclerosis, Parkinson's disease
• Severe and chronic pain, severe nausea
• Cachexia / wasting
• Seizure disorders, epilepsy
• Post-traumatic stress disorder
• Hepatitis C-associated symptoms
• Any other medical condition for which a certifying medical provider determines cannabis would provide therapeutic or palliative benefit

Patient access

• Possession: 2.5 ounces of harvested cannabis as a 30-day supply.
• Home cultivation: patients may grow up to 6 mature plants, plus immature plants and seedlings.
• Reciprocity: Maine honors out-of-state medical cards at any Maine medical-cannabis dispensary.
• Approved forms: flower, edibles, oils, tinctures, capsules, vapes, topicals.

Recreational penalties

Possession in excess of adult-use limits is governed by Title 28-B and 17-A. Most over-limit possession is a civil violation or misdemeanor; unlicensed manufacture or distribution scales to felony.

Patients and caregivers

• Patient minimum age: 18. Minor patients require parent/legal guardian as designated caregiver plus practitioner certification.
• Caregiver minimum age: 21.
• Caregivers per patient: up to 1 designated primary caregiver per patient; a caregiver may serve up to 5 patients.
• Caregiver registration: via the Maine Office of Cannabis Policy; criminal background check.

Patient registration steps

Maine's medical-cannabis registration is unusually light-touch compared to most state programs:

1. Schedule a visit with a Maine-licensed physician, nurse practitioner, or physician assistant willing to certify cannabis use. Maine practitioner discretion is broad; the provider may certify any condition for which cannabis is expected to provide therapeutic or palliative benefit.
2. The provider issues a written certification on the Office of Cannabis Policy form.
3. The patient does not apply for or receive a separate state ID card under current Maine practice. The provider certification itself is the operative document. The patient carries the certification (or a copy) and presents it at dispensaries for purchase.
4. Patients may designate a registered primary caregiver to assist with cultivation, possession, and transport. Caregivers complete a separate registration with the Office of Cannabis Policy and a Maine State Police background check.

The light-touch registration framework is one reason Maine's per-capita medical cardholder count appears lower than program participation suggests; many practitioner-certified patients are not tracked in a centralized state registry the way they would be in most states.

Reciprocity and visiting patients

Maine is one of the more reciprocity-friendly states. Maine medical-cannabis dispensaries are statutorily authorized to honor valid medical-cannabis cards from other US states. Practical notes:

• The visiting patient presents the out-of-state card plus a government-issued photo ID at the dispensary.
• Reciprocity covers possession on Maine soil within the program possession cap.
• Reciprocity does not extend to home cultivation (visitors cannot exercise Maine's expanded patient cultivation rights without Maine practitioner certification).

The adult-use track provides an alternate access pathway for visitors 21 or older.

Employment and workplace

Maine provides moderate employment protections. The medical-cannabis statute prohibits discrimination based on medical patient status, and the adult-use framework restricts some pre-employment testing:

• Adverse action restriction: medical patient status alone is not a permissible basis for adverse employment action.
• Pre-employment testing: Maine has restricted some pre-employment cannabis testing under amendments to the Maine Substance Abuse Testing Act, with carve-outs.
• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• Workers' compensation: post-incident testing positive for THC may affect benefits if impairment at the time of incident is established.

Hemp-derived intoxicants

Maine has restricted hemp-derived intoxicating cannabinoids through legislation that places delta-8 THC, delta-10 THC, and similar compounds under regulatory authority paralleling the cannabis framework. Outside the licensed adult-use and medical-cannabis supply chain, these products are not lawful for retail sale to consumers in Maine.

Caregiver-cultivator model

A distinctive feature of Maine's medical program is the caregiver-cultivator model. Registered caregivers may cultivate cannabis for up to 5 patients in addition to themselves. The model emerged before the 2016 adult-use legalization and provided a substantial portion of Maine's pre-2020 cannabis supply. Caregivers operate under separate licensing and reporting requirements distinct from licensed cultivators and dispensaries. The 2016 and subsequent amendments have adjusted the caregiver-cultivator framework to integrate with the adult-use commercial market while preserving the caregiver category.

Recent legislative history

Notable developments:

• 1999: Question 2 legalized medical cannabis use.
• 2009: Question 5 modified the medical program to add a dispensary framework alongside the caregiver-cultivator model.
• 2016: Question 1 legalized adult-use cannabis.
• 2020: licensed adult-use retail sales began October 9.
• 2023-2025: continued legislative work on caregiver-cultivator integration, social-equity licensing, hemp-derived intoxicant restrictions, and on-premises consumption pilots.
• 2026: ongoing review of tax structure, dispensary licensing, and patient-cultivation parameters.

The April 2026 federal Schedule III rescheduling order produced no immediate Maine legislative response.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Naval Air Station Brunswick (BRAC-closed but retains federal jurisdiction over certain parcels), Coast Guard installations), and interstate highways. Acadia National Park and several National Wildlife Refuges fall under federal jurisdiction where cannabis prohibition applies. I-95, I-295, I-195, and US-1 corridors see federal drug-interdiction activity, particularly at the Canadian border (a substantial portion of Maine borders New Brunswick and Quebec, where US Customs and Border Protection enforces federal prohibition).